What the paediatricians need?the launch of paediatric research in Europe
Author:
- 22 February 2005
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 164 (5) , 263-265
Abstract
Most parents and many paediatricians are not aware that medicines for children are often not tested, labelled, or approved for their prescribed use. In 1997, the Food and Drug Administration developed incentives for pharmaceutical companies to perform paediatric research in medications. The European Commission brought out its proposal for paediatric incentives after in-depth internal reflection. Now it should be adapted quickly to boost pharmaceutical paediatric research in the EU as soon as possible. Conclusion:The proposal must be balanced and aware that both incentives and requirements are mandatory in order to maintain and stimulate paediatric research on medicines in Europe.Keywords
This publication has 2 references indexed in Scilit:
- Off label use—label off use?Annals of Oncology, 2003
- Fifth EMEA/IFAPP Conference. Meeting report: Clinical studies at the extremes of ageInternational Journal of Pharmaceutical Medicine, 2002